Research graph
References from Transcatheter embolization as a rescue therapy for refractory pelvic kaposiform hemangioendothelioma with Kasabachi–Merritt phenomenon: a case report. Local targets link to admitted publications; unresolved targets remain external evidence.
Treatment practices and response in kaposiform hemangioendothelioma: a multicenter cohort study
10.1002/pbc.30779 · 2024 · External reference
Retrospective multicenter study on childhood kaposiform hemangioendothelioma (2007–2024): report of the section of childhood vascular anomalies of the Polish Society of Pediatric Oncology and Hematology
10.1002/1545-5017.70086 · 2026 · External reference
Kaposiform hemangioendothelioma: atypical features and risks of Kasabach–Merritt phenomenon in 107 referrals
10.1016/j.jpeds.2012.06.044 · 2013 · External reference
Kasabach–Merritt syndrome: pathogenesis and management
10.1046/j.1365-2141.2001.02453.x · 2001 · External reference
The VASCERN-VASCA diagnostic and management pathways for kaposiform hemangioendothelioma
10.1007/s00431-025-06631-6 · 2025 · External reference
Efficacy and safety of high-vs low-dose sirolimus in patients with kaposiform hemangioendothelioma: a randomized clinical trial
10.1016/j.jaad.2025.03.023 · 2025 · External reference
Capillary hemangioma with extensive purpura: report of a case
10.1001/archpedi.1940.01990160135009 · 1940 · External reference
Radiotherapy for life-threatening mediastinal hemangioma with Kasabach–Merritt syndrome
10.1002/pbc.20767 · 2007 · External reference
ISSVA classification
10.1053/j.sempedsurg.2014.06.016 · 2014 · External reference
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: a multicenter retrospective study
10.1002/ijc.30775 · 2017 · External reference
Consensus-derived practice standards for complicated kaposiform hemangioendothelioma
10.1016/j.jpeds.2013.03.080 · 2013 · External reference
Decreased vascularization of retroperitoneal kaposiform hemangioendothelioma induced by treatment with sirolimus explains relief of symptoms
10.1016/j.clinimag.2015.01.003 · 2015 · External reference
Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial
10.1182/blood.2021014027 · 2022 · External reference
Successful sirolimus plus aspirin treatment of refractory kaposiform hemangioendothelioma with Kasabach–Merritt phenomenon
10.1002/1545-5017.70260 · 2026 · External reference
Successful treatment of Kasabach–Merritt syndrome with transarterial embolization and corticosteroids
10.1016/j.jpedsurg.2012.12.049 · 2013 · External reference
Combined transarterial sclerotherapy and embolization with systemic chemotherapy followed by everolimus in kaposiform hemangioendothelioma with Kasabach–Merritt syndrome
10.1016/j.jvir.2020.12.027 · 2021 · External reference
Transarterial embolization of a cervicofacial hemangioma associated with Kasabach–Merritt syndrome in a premature neonate
10.1016/j.jvir.2013.08.026 · 2013 · External reference
Transarterial embolization of giant liver hemangiomas associated with Kasabach–Merritt phenomenon
10.1080/02841850701326917 · 2007 · External reference
Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma
10.1002/ijc.33406 · 2021 · External reference
